CRP and type 2 diabetes mellitus: This study aims to evaluate the clinical utility of Lp-PLA2, LDL-C, HDL-C, hs-CRP, leukocyte count, FPG, and HbA1c in assessing the risk and severity of AIS in T2DM patients.